Purpose: Pulmonary edema (PE) is a common medical emergency associated with high in-hospital mortality.
The association between systolic blood pressure (SBP) at admission and adverse in-hospital events has not been wellstudied in this population.
Objective: To evaluate the association between adverse inhospital outcomes in patients hospitalized for acute heart failure syndromes (AHFS) presenting with PE according to admission SBP.
Methods:
The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry enrolled 3224 consecutive patients admitted for AHFS, over a 12-month period. Patients were classified into the five clinical profiles at admission: acute decompensated heart failure (ADHF), cardiogenic shock (CS), pulmonary edema (PE), right heart failure (RHF), and hypertensive heart failure (HT HF). Patients with PE were divided into three groups by admission SBP: < 110 mmHg, 110-140 mmHg, and >140 mmHg.
Results: PE clinical profile included 28.7% (n = 924) of RO AHFS population. The mean age was 71 ± 10.4 years and 59% were male. Ischemic etiology was reported for 71% of patients and mean LVEF was 39.2 ± 13.2%. Mean admission SBP was 167 ± 43 mmHg and SBP < 110mmHg, 110-140 mmHg, and >140 mmHg, respectively, included 14.6%, 19.6%, and 65.8% of patients. In-hospital mortality was 7.4%. Discharge outcomes by admission SBP are shown in Table 1 .
Conclusions:
Patients admitted for PE can be risk-stratified at admission by initial SBP. For patients discharged alive, low SBP and worsening renal function during hospitalization may limit the implementation of evidence-based therapies, potentially contributing to post discharge mortality and morbidity. Population: From January to June 2011 108 ACPE complicated by RE have been treated with medical therapy and NPPV via helmet. RE is defined by a D-pCO2 >2 mmHg value at the entry. D-pCO2 is the difference between pCO2 measured and awaited (pCO2 awaited = 1, 5*HCO3+8).
Methods:
Patients with cardiogenic shock, cronic respiratory failure (CRF), anaemia, and other not cardiac causes of dispnea have been excluded. Initial ventilatory settings were continuous positive airway pressure (CPAP) mode, 5 cm H2O, with pressure support ventilation of 10 to 20 cm H2O titrated to achieve a respiratory rate less than 25 breaths/min and an exhaled tidal volume of 7 mL/kg or more. Ventilator settings were adjusted following arterial blood gases (ABG) results.
Results: Failure to improve ABG values was the reason for ETI in 2 patients (2.16%). One patient has died during treatment (1.8%). two patients did not tolerate the helmet (7%).
No complications developed for the use of the helmet.
The average duration of NPPV was 27 ± 12 h. After 12 hours of the NINV in these patients has determined an improvement of the cardiac frequency from 109 ± 16 to 81 ± 12 (p = 0, 002), respiratory frequency from 38 ± 6 to 19 ± 3 (p = 0, 002). Arterial blood saturation increased from 74% ± 14 to 96% ± 5 (p < 0, 0001), pH from 7, 21 ± 0, 10 to 7, 40 ± 0, 09 (p < 0.001), pO2 from 52 ± 16 to 100 ± 31 (p < 0, 001) as well, while pCO2 decreased from 66 ± 17 to 41 ± 10 (p < 0, 001). Significant variations of systolic and diastolic blood pressure where not reported.
Conclusions:
In patients with acute cardiogenic pulmonary edema, noninvasive ventilation induces a more rapid improvement in respiratory distress and metabolic disturbance than does standard oxygen therapy has no effect on short-term mortality. The application of NPPV in clinical practice in ICCU is a cardiologist's effective and safe alternative to ETI for a patients affected by respiratory failure associated with ACPE.
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Optimization of impella 5.0 implantation using mini-sternotomy approach in post myocardial infarction cardiogenic shock L Barandon 1 , F Casassus 1 , J Calderon 1 , L Leroux 1 , A Ouattara 1 and X Roques 1 1 Haut-Leveque Hospital, Pessac, France Introduction: Acute MI with refractory cardiogenic shock remains a difficult situation with a very high mortality rate in which the early management by LVAD can be lifesaving. Impella Recover LP pump 5.0 ® (Abiomed, Inc. Danvers, MA) is an intravascular microaxial pump developed to unload the left ventricle and to ensure a systemic blood flow around 5 L/min. The pump was designed to be implanted through a femoral artery cut-down or more recently using a right subclavian artery approach. These surgical procedures are sometimes rendered technically difficult due to the presence of PVD, small vessels or vasospasm induced by vasoactive drugs. We propose a new technique for surgical implantation using a mini-sternotomy which aims at avoiding vascular complications and facilitating the rehabilitation of patients.
Method: Under general anesthesia, including monitoring by a right BP measurement, TOE and Swan-Ganz catheter, a mini-sternotomy is performed. The sternum is sectioned at the second or the third intercostal space. This approach allows easy access to the ascending aorta after opening the pericardium. After heparinization (1 mg/Kg), a 10 mm of dacron prosthesis is implanted under a tangential clamping of the ascending aorta. A skin contra-incision allows the device to move through an intercostal space avoiding mobilization of the pump and easy closing. The Impella device is introduced in the prothesis, through the aortic valve using fluoroscopy and TOE, taking care to not pass through the chordae of the mitral valve. Using TOE, the correct position of the Impella is controlled before turning on the pump at lowest level (P1) and the pump flow above the aortic valve front to the coronary ostia is verified. The performance level is then gradually increased to reach the P8 level (close to 5L/min).
Results:
We performed this technique for 14 patients (including 2 redo patients) in whom angiography found severe iliac artery lesions, or small diameters of the subclavian vessels. No failures of the procedure were found but one patient had a pericardial effusion requiring drainage. All patients had high doses of catecholamines, quickly weaned, and an intra aortic balloon pump. 9 patients were weaned from the Impella 5.0, one required the implantation of a HeartMate 2 (Thoractec ® ). Four patients died in the follow up, two due to multiorgan failure, 1 for sepsis and one with severe hemoptysis. We did not meet any local infection or any secondary mobilization.
Conclusion: we encourage the cardiac surgeons to consider the mini-sternotomy approach in the particularly setting in the of post MI cardiogenic shock. 
The average K+ concentration was 3.81 ± 0.33 in 1st, 4.44 ± 0.16 in 2nd and 5.24 ± 0.50 mmol/L in 3rd tertile. The most important parameter, in-hospital mortality, was from 1st to 3rd tertile: 5.66%, 1.42% and 9.01%, respectively. Diabetes mellitus was more prevalent in 3rd tertile vs 2nd (41.06% vs 32.06%, p = 0.0435) and vs 1st (41.06% vs 27.86%, p = 0.00266). Glycemia was higher in 3rd tertile vs 1st (7.40 ± 4.11 vs 6.65 ± 3.29 mmol/L, p = 0.04710). Coronary artery disease prevalence was higher in 3rd vs 2nd tertile (76.68% vs 65.31%, p = 0.0134). Atrial fibrillation was more common in 1st vs 2nd tertile (55.56% vs 43.54%, p = 0.01420). Serum urea and creatinine were higher and sodium concentration lower from 1st to 3rd tertile. Systolic, diastolic, mean and pulse pressure and left ventricle global contractile function were similar between the tertiles. Enlargement of left ventricle was more common in 1st vs 3rd tertile (74.84% vs 63.69%, p = 0.03302). Left atrial and right ventricle enlargement were more frequent in 1st vs 2nd tertile. Septum was ticker in 3rd vs 1st tertile 11.75 ± 2.69 vs 10.78 ± 2.41 mm (p = 0.03695). Background: Cardiogenic shock results is a physiologic state in which inadequate tissue perfusion results from cardiac dysfunction, most commonly following ST-segment elevation myocardial infarction (STEMI).
Conclusion

Purpose:
The purpose of the present study was to evaluate the prevalence rate of cardiogenic shock and in-hospital mortality following STEMI treated with primary percutaneous coronary intervention (PCI) by transradial access.
Methods:
We studied 912 patients with STEMI treated by primary PCI included in a national multicenter registry. We considered 2 groups: patients with transradial (TR) access and patients with transfemoral (TF) access. We compared in the 2 groups age, gender, cardiovascular risk factors, history of chronic renal failure, ejection fraction (EF) at admission, number of vessels with lesions and in-hospital mortality. Cardiogenic shock was defined by the presence of at least one of the following: Killip class IV, use of inotropics drugs and intraaortic balloon pump.
Results: TR access was used on 473 pts (51.9%). The patients with TR access were younger (62.1 ± 13.2 vs. 63.8 ± 13.5 years; p = 0.048) and more often male (80.8 vs. 73.3%; p = 0.008). There were no differences in cardiovascular risk factors, history of chronic renal failure and EF at admission in the 2 groups. The patients with TF access had more one-vessel coronary artery disease (CAD) (88.3 vs. 80.0%, p < 0.001) and less two-vessel CAD (8.7 vs. 17.1%; p < 0.001). There were no differences in three-vessel disease and left main coronary artery int the 2 groups. The patients with TR access received less therapy with inotropics drugs (5.3 vs. 12.8%; p < 0.001) and have a lower prevalence of Killip class IV (3.2 vs. 9, 6%; p < 0.001). There were no differences in the use of intraaortic balloon pump in the 2 groups (TR: 1.7 vs. TF: 2.5%; p = 0.390).
The TR access was associated with lower in-hospital mortality (2.1 vs. 8, 2%; p < 0.001).
Conclusions:
Our results suggest that radial access for primary PCI is associated with lower in-hospital mortality and lower cardiogenic shock, constituting as the preferred vascular access in STEMI treated with primary PCI. Introduction: Elevated levels of the cardiac muscle protein troponin T (cTnT) are frequently found in the clinical setting of acute ischemic stroke. The underlying pathomechanism of troponin release and its clinical significance remains uncertain. Therefore, elevated troponin levels in acute ischemic stroke remain a clinical enigma.
Methods: All consecutive patients at our institution with acute MRI-or CT-confirmed ischemic stroke admitted within 72 hours after symptom onset had cTnT-levels determined on the day of admission and the following day.
Patients with increased cTnT (>0.05 µg/l) without renal insufficiency, without ST-elevation on ECG, who were able and willing to give informed consent (modified Rankin Score (mRS) >4) underwent diagnostic coronary angiography within 72 hours.
The primary endpoint of this ongoing study is detection of coronary culprit lesions with acute plaque rupture, suggestive of true acute coronary syndrome. The secondary endpoint is the localization of stroke in the cerebral imaging.
Results: Elevated troponin levels were found in 99 of 742 (13%) patients with acute ischemic stroke. Troponin-levels were 0, 080 [0, 052 -0, 152] on day 1 (Median [IQR]; µg/dl) and 0, 123 [0, 089 -0, 213] on day 2.Reasons for exclusion from coronary angiography were renal insufficiency (N = 34), unable (N = 25) or unwilling (N = 8) to give informed consent or premorbid mRS (N = 19). Therefore, 13 patients underwent coronary angiography (median [IQR] age; 77 [68, 5-82, 5] years, 54% female). A potential culprit lesion as underlying mechanism of troponin release was found in only 1 patient. However, also in this case TIMI Flow was III (normal). One patient underwent stenting of a coronary stenosis after the acute phase of ischemic stroke as a staged procedure. Of all patients included, insular cortex was affected in 44% with troponin elevation and 26% without troponin elevation (p = 0.003).
Conclusion:
In our ongoing study, acute plaque rupture was not the predominant underlying mechanism of troponin release in patients with acute ischemic stroke. This finding could have significant impact in patient management. Involvement of the insular cortex was associated with a higher chance of troponin release.
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Direct comparison of threenatriuretic peptides in chronic hemodialysis: insights for their use in acute cardiac care
